toomuchtime_
Gold Member
- Dec 29, 2008
- 20,572
- 5,365
- 280
Israeli researchers are the first in the world to have documented that the injection of stem cells from aborted human fetuses can trigger tumors.
Stem cells, especially those from few-day-old embryos, are considered by many to be a potential cure for a wide variety of chronic disorders - from Parkinson's and Alzheimer's to diabetes and heart disease - because they have the ability to produce new cells of all types for the repair of diseased organs.
But the new research, based on the case of a now-16-year-old Israeli youth suffering from a rare genetic degenerative disease who underwent the highly experimental injections in Russia, is the first documented case of a human brain tumor - albeit a benign, slow-growing one - after fetal stem cell therapy, and sounds an alarm that future stem cell use must be preceded by extensive research.
The patient, born here to parents of Moroccan origin, developed ataxia telangiectasia (AT) as a young child. Degeneration of a certain brain region gradually robs these children of movement, and a faulty immune system leads to frequent infections and cancers. Most victims die in their teens or early 20s.
Although the boy's doctors at Sheba Medical Center, Tel Hashomer, urged the desperate parents against it, they took him to an unnamed clinic in Moscow for injections of fetal stem cells into his brain and spinal cord.
He returned to Russia twice - at age 10 and 12 - for more injections.
Then, at the age of 13, he developed painful headaches, and an MRI scan showed he had tumors in several parts of the brain and the spinal cord.
Two-and-a-half years ago, hematology Prof. Gideon Rechavi, head of Sheba's Cancer Center and Tel Aviv University's Cancer Biology Center, headed a team that investigated the case and found after extensive pathological and genetic research that the tumors were not germane to the patient, but were sourced from at least two fetuses whose foreign tissue had been injected into him.
For example, the tumors contained both XX (female) and XY (male) cells, while if they had come from the boy's body they could not have female chromosomes. They also had two normal copies of the ATM gene, which causes AT when mutated. Since the boy has AT, those genes cannot be his.
The team noted, however, that the fact that the boy has AT may have facilitated the growth of the tumors because of the weak immune system in such patients.
'Stem cell injections may causer tumors' | Health | Jerusalem Post
Stem cells, especially those from few-day-old embryos, are considered by many to be a potential cure for a wide variety of chronic disorders - from Parkinson's and Alzheimer's to diabetes and heart disease - because they have the ability to produce new cells of all types for the repair of diseased organs.
But the new research, based on the case of a now-16-year-old Israeli youth suffering from a rare genetic degenerative disease who underwent the highly experimental injections in Russia, is the first documented case of a human brain tumor - albeit a benign, slow-growing one - after fetal stem cell therapy, and sounds an alarm that future stem cell use must be preceded by extensive research.
The patient, born here to parents of Moroccan origin, developed ataxia telangiectasia (AT) as a young child. Degeneration of a certain brain region gradually robs these children of movement, and a faulty immune system leads to frequent infections and cancers. Most victims die in their teens or early 20s.
Although the boy's doctors at Sheba Medical Center, Tel Hashomer, urged the desperate parents against it, they took him to an unnamed clinic in Moscow for injections of fetal stem cells into his brain and spinal cord.
He returned to Russia twice - at age 10 and 12 - for more injections.
Then, at the age of 13, he developed painful headaches, and an MRI scan showed he had tumors in several parts of the brain and the spinal cord.
Two-and-a-half years ago, hematology Prof. Gideon Rechavi, head of Sheba's Cancer Center and Tel Aviv University's Cancer Biology Center, headed a team that investigated the case and found after extensive pathological and genetic research that the tumors were not germane to the patient, but were sourced from at least two fetuses whose foreign tissue had been injected into him.
For example, the tumors contained both XX (female) and XY (male) cells, while if they had come from the boy's body they could not have female chromosomes. They also had two normal copies of the ATM gene, which causes AT when mutated. Since the boy has AT, those genes cannot be his.
The team noted, however, that the fact that the boy has AT may have facilitated the growth of the tumors because of the weak immune system in such patients.
'Stem cell injections may causer tumors' | Health | Jerusalem Post